Cleared Traditional

The iMask Child's Face Mask (K202831) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K202831 · Pac-Dent, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2021
Decision
335d
Days
Class 2
Risk

K202831 is an FDA 510(k) clearance for the The iMask Child's Face Mask. Classified as Pediatric/child Facemask (product code OXZ), Class II - Special Controls.

Submitted by Pac-Dent, Inc. (Brea, US). The FDA issued a Cleared decision on August 26, 2021 after a review of 335 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 878.4040 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Pac-Dent, Inc. devices

Submission Details

510(k) Number K202831 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 25, 2020
Decision Date August 26, 2021
Days to Decision 335 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
206d slower than avg
Panel avg: 129d · This submission: 335d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OXZ Pediatric/child Facemask
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4040
Definition A Pediatric/child Facemask Is Intended To Be Worn By The Patient/child To Provide Protection For The Respiratory Tract. It Is A Single Use, Disposable Device That Is Provided Non-sterile. The Facemask Is Recommended For Use In A Healthcare Setting With Appropriate Adult Supervision.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - OXZ Pediatric/child Facemask

Devices cleared under the same product code (OXZ) and FDA review panel - the closest regulatory comparables to K202831.
PRIMED Pediatric Facemask
K213427 · Primed Medical Products, Inc. · Nov 2022
Dukal Corporation Level 1 Pediatric Face Mask
K210321 · Dukal Corporation · Mar 2022
Child Face Mask
K201514 · Shandong Shengquan New Material Co., Ltd. · Oct 2021
Medicom SafeMask Sofskin Pediatric Procedure Earloop Face Masks (ASTM Level 1), Medicom SafeMask Sofskin Pediatric Procedure Earloop Face Masks, Medicom SafeMask Premier Pediatric Procedure Earloop Face Masks (ASTM Level 1), Medicom SafeMask Premier Pediatric Procedure Earloop Face Masks (ASTM Level 1)
K190308 · Amd Medicom, Inc. · Sep 2019